Strides Arcolab reports 31.34% rise in Q2 consolidated net profit

27 Jul 2012 Evaluate

Strides Arcolab has reported results for second quarter ended June 30, 2012.

On standalone basis, the company has reported a net loss of Rs 19.90 crore for the quarter ended June 30, 2012, against net profit of Rs 14.60 crore for the corresponding period last fiscal.  However, total income increased by 1.09% at Rs 199.84 crore during the quarter under review from Rs 197.68 crore in the year-ago period.

On consolidated basis, the company has posted a rise of 31.34% in its net profit at Rs 90.48 crore for the quarter ended June 30, 2012 as compared to Rs 68.89 crore for the same quarter in the previous year. However, total income has decreased by 7.74% at Rs 550.55 crore for quarter under review as compared to Rs 596.74 crore for the quarter ended June 30, 2011.

Strides Pharma Scien Share Price

954.85 13.90 (1.48%)
03-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1531.05
Dr. Reddys Lab 6428.05
Cipla 1482.30
Zydus Lifesciences 1093.45
Lupin 1637.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.